Skip to main content
Livermore
Livermore
ZHEN

Cloverfields Capital Group, LP

SEC CIK
0001819581
Latest filing
Aug 13, 2026

NVO holding history

Novo Nordisk A S in every 13F filed by Cloverfields Capital Group, LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

NVO overviewAll 13F holders of NVOFull Q2 2026 holdings

Shares (Q4 2025)
0
Sold out in Q4 2025
Value
$0
% of portfolio
0.0%
Quarters held
19
Since Q1 2021
Holdings of NVO by Cloverfields Capital Group, LP, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q4 20250$00.0%−36,354−100.0%Sold outHolders
Q3 202536,354$2.02M0.6%−3,368−8.5%ReducedHolders
Q2 202539,722$2.74M0.8%+13,533+51.7%AddedHolders
Q1 202526,189$1.82M0.6%+313+1.2%AddedHolders
Q4 202425,876$2.23M0.7%+2,900+12.6%AddedHolders
Q3 202422,976$2.74M0.9%−3,773−14.1%ReducedHolders
Q2 202426,749$3.82M1.3%+239+0.9%AddedHolders
Q1 202426,510$3.40M1.1%+283+1.1%AddedHolders
Q4 202326,227$2.71M1.1%−2,099−7.4%ReducedHolders
Q3 202328,326$2.58M1.2%00.0%UnchangedConverted for a 2-for-1 splitHolders
Q2 202314,163$2.29M0.7%+5,024+55.0%AddedHolders
Q1 20239,139$1.45M0.4%+3,949+76.1%AddedHolders
Q4 20225,190$702.4K0.2%−3,172−37.9%ReducedHolders
Q3 20228,362$833.0K0.3%+70+0.8%AddedHolders
Q2 20228,292$924.0K0.3%−145−1.7%ReducedHolders
Q1 20228,437$937.0K0.3%−2,061−19.6%ReducedHolders
Q4 202110,498$1.18M0.4%00.0%UnchangedHolders
Q3 202110,498$1.01M0.3%+73+0.7%AddedHolders
Q2 202110,425$873.0K0.3%+127+1.2%AddedHolders
Q1 202110,298$694.0K0.2%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.